HIT Consultant

MAY 9, 2024

Triomics partners include the Collaboration for Oncology-focused LLM Training (COLT), a consortium of leaders from a dozen NCI-designated cancer centers, and the Cancer Informatics for Cancer Centers (CI4CC) Society. Provider burnout: The overwhelming workload can contribute to provider dissatisfaction and burnout.

Quality of Care 52

Quality of Care Integration Doctors Nursing 52

HIT Consultant

MAY 13, 2024

What You Should Know: – Flatiron Health , an oncology-focused healthtech company, and the Association of Cancer Care Centers (ACCC) , a powerful network of cancer care professionals, are proud to announce a new collaboration. Pal, MD, FASCO, Chair, ACCC’s Community Oncology Research Institute (ACORI). “We

Integration 52

Integration Healthcare Providers Life Sciences Healthcare 52

Fierce Healthcare

DECEMBER 7, 2021

House bill aims to delay 6% in Medicare cuts, postpones radiation oncology model. Tue, 12/07/2021 - 14:01.

Medicare 335

Medicare 335

Healthcare It News

FEBRUARY 15, 2024

Amrita Hospital in Faridabab announced that the head of its Radiation Oncology department has received a grant from the government to develop a robot-assisted ultrasound system for image-guided therapies and hyperthermia for cancer treatment.

Telemedicine 231

Telemedicine Doctors Hospitals Integration 231

Fierce Healthcare

JANUARY 16, 2024

Industry Voices—Oncology researchers must rethink their definition of what is considered a "good" clinical research site hlandi Tue, 01/16/2024 - 12:49

130

130

HIT Consultant

AUGUST 28, 2023

Annmarie Ison, Head of Customer Service for the Oncology Software Solutions Business Line at Elekta The complex and dynamic landscape of multimodal cancer care is boosting demand for oncology-specific technological innovations. Integrating supplementary systems into a workflow requires seamless connectivity with existing platforms.

Integration 98

Integration Health Data Accountability Healthcare 98

HIT Consultant

MAY 15, 2023

Flatiron’s new Integrated RWE Solutions will include data and end-to-end services to provide a more flexible and fit-for-purpose approach to address growing oncology RWE needs—from early development through late-stage commercialization.

Integration 98

Integration Life Sciences Pharmaceuticals Health Data 98

HIT Consultant

JANUARY 30, 2024

What You Should Know: – PathAI , a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. A Proven Partner in Precision Oncology Since its launch, PathExplore has established itself as a trusted ally in the fight against cancer.

Life Sciences 97

Life Sciences 97

HIT Consultant

APRIL 27, 2023

Haystack Oncology was founded to dramatically improve patient outcomes with transformative precision oncology. The acquisition will leverage Quest’s expertise and scale in oncology, genomics and pathology.

Life Sciences 98

Life Sciences Healthcare 98

HIT Consultant

FEBRUARY 28, 2023

What You Should Know: – Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery and development in oncology.

Life Sciences 98

Life Sciences 98

HIT Consultant

OCTOBER 11, 2023

community oncology setting. Ontada will conduct real-world research (RWR) that aims to strengthen the scientific understanding of the natural history of rare cancers by leveraging Ontada’s community oncology footprint and unique RWD. Food and Drug Administration (FDA) to advance the use of real-world data (RWD) in the U.S.

Life Sciences 98

Life Sciences 98

HIT Consultant

MARCH 8, 2023

an oncology real-world data and analytics company, today announced a new partnership with Genomic Testing Cooperative (GTC), a molecular testing company. What You Should Know: – COTA, Inc.,

98

98

Fierce Healthcare

JULY 14, 2023

Chutes & Ladders—Oncology Care Partners names new chief health officer; Notable snatches up new CMO aburky Fri, 07/14/2023 - 13:38

130

130

HIT Consultant

FEBRUARY 21, 2023

What You Should Know: – Vysioneer , a provider of applied AI for Oncology, today announced a data-sharing agreement with Pfizer , a global leader in pharmaceuticals. The agreement aims to lay the foundation for the application of AI in oncology clinical trials.

Pharmaceuticals 98

Pharmaceuticals Life Sciences 98

HIT Consultant

JULY 28, 2022

What You Should Know: Elevation Oncology, a clinical-stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers, today announced that it has secured a $50M senior secured loan facility from funds managed by K2 HealthVentures.

Pharmaceuticals 98

Pharmaceuticals 98

HIT Consultant

MARCH 17, 2023

Lamont, Global RWE Data Strategy, Access & Enablement at IQVIA and General Manager The American Cancer Society’s Cancer Statistics 2023 report highlighted a few major accomplishments within oncology, such as decreased cancer mortality rates and increased trial diversity. However, there is still much work to be done.

Life Sciences 98

Life Sciences Healthcare Providers Healthcare 98

Healthcare ECONOMIST

JUNE 1, 2023

At least 2060 oncologists (64% medical, 36% radiation) were affiliated with clinics at the time of initial PE acquisition, constituting an estimated 10% (1318 of 13 531) of practicing medical oncologists and 15% (742 of 4886) of radiation oncologists.

Medical Services 83

Medical Services 83

Fierce Healthcare

FEBRUARY 3, 2023

Jude seats new oncology chair, hires first-ever chief business innovation officer to roll out $12.9B Chutes & Ladders—St. strategic plan aburky Fri, 02/03/2023 - 09:49

130

130

HIT Consultant

NOVEMBER 14, 2022

an oncology real-world data and analytics company announced a partnership with Google Cloud to bring clarity to unstructured oncology data through the latest advancements in machine learning and natural language processing. What You Should Know: COTA, Inc. , Why It Matters.

Life Sciences 96

Life Sciences Health Data 96

HIT Consultant

JUNE 14, 2022

Comprehensive Diagnostics for Oncology Patients in Central Florida. . – The collaboration combines Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer, Pierian’s leading-edge clinical genomics workflow, and precision medicine services that provide the most relevant insights in the industry.

95

95

HIT Consultant

DECEMBER 5, 2023

What You Should Know: – Syapse ®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of their four-year collaboration agreement.

52

52

Fierce Healthcare

MAY 9, 2024

Triomics, an oncology-focused artificial intelligence company, raised $15 million to help automate cancer providers’ workflows. Triomics raised $15 million for its oncology-focused generative AI. Academic literature supports the model's accuracy and efficacy in matching oncology patients with a ranked list of clinical trials.

130

130

Healthcare ECONOMIST

JULY 18, 2022

The Oncology Care Model (OCM) is dead. The Oncology Care Model was a voluntary, alternative payment model (APM), that “ included financial and performance accountability for episodes of care surrounding chemotherapy administration to cancer patients. Note: Yes, there is a 1 year gap between the end of OCM and the start of EOM].

Medicaid 80

Medicaid Quality of Care Accountability Patient Experience 80

Fierce Healthcare

MARCH 22, 2024

Oncology was a major focus at this year’s SXSW conference. Uncomfortable waiting rooms. Revealing hospital gowns. Confusing insurance. Exhausting travel between appointments.

Hospitals 332

Hospitals 332

HIT Consultant

JUNE 22, 2023

What You Should Know: Quest Diagnostics announced that it has completed its $450M acquisition of Haystack Oncology. Acquired back in April, the acquisition will leverage Quest’s expertise and scale in oncology, genomics and pathology.

Healthcare 52

Healthcare 52

Healthcare ECONOMIST

FEBRUARY 21, 2023

2022) use data between 2002-2021, and found that FDA approved: …176 new malignant hematology and oncology indications based on single-arm trials, including 116 accelerated approvals (AAs) and 60 traditional approvals. These are becoming increasingly common. Agrawal et al.

82

82

HIT Consultant

JANUARY 5, 2022

What You Should Know: – Syapse , a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health system setting. Importance of Biomarker Testing.

Life Sciences 97

Life Sciences 97

HIT Consultant

APRIL 22, 2022

What You Should Know: – Mayo Clinic has signed a research agreement with VUNO , a global medical artificial intelligence (AI) company to develop advanced AI-driven precision oncology solutions to deliver precision oncology care.

Life Sciences 98

Life Sciences 98

HIT Consultant

MARCH 17, 2022

What You Should Know: – Today, Canopy announced it is launching out of stealth with $13 million in funding to work with leading oncology practices all over the country to help deliver high-quality care to cancer patients when they aren’t in the doctor’s office. Intelligent Care Platform for Oncology.

Patient Experience 98

Patient Experience Nursing Integration Hospitals 98

Healthcare ECONOMIST

JANUARY 27, 2023

In the past, I have written about the Enhancing Oncology Model (EOM), including an overview of the EOM program as well as a more detailed review of EOM’s payment methodology. The authors bring up the fact that EOM’s predecessor–the Oncology Care Model (OCM)–was not particularly successful based on the evidence.

Medicare 67

Medicare Quality Improvement Quality of Care Patient Experience 67

HIT Consultant

DECEMBER 15, 2021

Bringing Data-Driven Approach to Oncology Care. Our recently launched Precision Oncology Program focuses on the molecular profile of each individual cancer so that the most appropriate personalized treatment options may be considered.

Healthcare Providers 98

Healthcare Providers Healthcare 98

Home Health Care

JANUARY 4, 2024

The company announced a strategic investment from Oncology Ventures — a cancer-focused venture capital fund — that will move forward the development and expansion of Reimagine Care’s product development and commercial acceleration, the company announced. “The Nardi was named Reimagine’s CEO in July and has hit the ground running.

46

46

HIT Consultant

AUGUST 23, 2023

What You Should Know: PicnicHealth, a patient-centered health technology company, today announced its entry into the real-world data market for oncology.

Primary Care 52

Primary Care Health Technology 52

Home Health Care

JUNE 28, 2022

Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) are taking steps to improve oncology care and primary care this week. After all, both primary and oncology care have been woven into the home-based care landscape more and more over the last few years.

Primary Care 96

Primary Care Medicaid Medicare Quality of Care 96

Home Health Care

MARCH 20, 2022

Yet another company is tasking itself with taking on oncology care outside of brick-and-mortar settings. An “intelligent care platform” for oncology, Canopy works with oncology practices to care for patients when they are outside of the hospital. But in oncology, all the incentives align so beautifully.

Doctors 89

Doctors Hospitals Integration 89

Health Populi

JUNE 5, 2023

It’s time for the annual ASCO conference, currently convening the American Society for Clinical Oncology in Chicago. ” The second point I’ll pull out of this report comes from a section of important data on diversity and inclusivity in oncology. in 2023, and millions of more people worldwide.

Patient Experience 62

Patient Experience Medicaid Prevention Pharmaceuticals 62

HIT Consultant

SEPTEMBER 13, 2023

– The program is set to launch in the first quarter of 2024 and will enable physicians to refer patients via Congenica’s Precision Oncology solution to the myTomorrows platform where they can search for applicable trials and request enrollment. .

Life Sciences 52

Life Sciences 52